- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bausch Health Companies Inc (BHC)
The Bausch Health share price today is 5.72, view NYSE BHC stock exchange data. Track the latest Bausch Health share price with real-time updates on BHC stock performance including market cap, day range, 52-week range and dividend yield. Access BHC charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.71
6.29
52 wk Range
4.41
8.69
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.716.29
52 wk Range
4.418.69
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BHC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
7.57
Upside
+32.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
Analyst Ratings
1 Buy
8 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 7.57
(+32.37% Upside)
Bausch Health Companies Inc SWOT Analysis
Financial Resilience | Bausch Health's Q3 2024 results showcase robust growth, with revenues of $2.51 billion marking a 12% year-over-year increase and 9% organic growth |
Debt Dilemma | Explore the complexities of Bausch Health's $21.5 billion debt burden and its impact on strategic initiatives, including potential bankruptcy concerns |
Strategic Crossroads | Delve into Bausch Health's plans for asset separation, particularly the Bausch+Lomb division, and how debt issues may affect these crucial moves |
Market Sentiment | Analysts offer mixed views, with price targets ranging from $8 to $11, reflecting the tension between strong performance and financial challenges |
Bausch Health Companies Inc Earnings Call Summary for Q1/2026
- Bausch Health Q1 2026 EPS of $0.78 beat estimates by 14.71%; revenue of $2.52B exceeded forecasts by 4.13%, marking 12th straight growth quarter.
- Adjusted EBITDA surged 27% YoY to $837M; adjusted gross margin improved 100 bps to 70.9%, driven by strong Salix and Solta segment performance.
- Company projects Q2-Q4 EPS range of $1.02-$1.42; plans to launch 30+ new products in EMEA and expand Latin American presence to sustain growth.
- Stock declined 0.71% to $5.63 in after-hours trading despite earnings beat, reflecting broader market pressures rather than company-specific concerns.
- CEO Papa cited operational excellence; CFO Herendeen noted litigation settlements enhance financial flexibility for strategic growth investments.
Last Updated: 30-04-2026, 03:36 am
Read Full TranscriptEarnings
Latest Release
29-04-2026
EPS / Forecast
0.78 / 0.68
Revenue / Forecast
2.52B / 2.42B
Compare BHC to Peers and Sector
Metrics to compare | BHC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBHCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | 19.2x | −0.5x | |
PEG Ratio | 0.00 | 0.11 | 0.00 | |
Price/Book | −3.9x | 1.4x | 2.6x | |
Price / LTM Sales | 0.2x | 2.0x | 3.2x | |
Upside (Analyst Target) | 39.9% | 71.5% | 48.8% | |
Fair Value Upside | Unlock | 24.4% | 6.9% | Unlock |
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Bausch Health (BHC) Share Price Today?
The Bausch Health share price today is 5.72.
What is the current Bausch Health (BHC) share price and day range?
As of 01-05-2026, the Bausch Health share price is 5.72, with a previous close of 5.72. The share price has ranged from 5.71 to 6.29 today, while the 52-week range spans from 4.41 to 8.69.
What Is the Bausch Health Market Cap?
As of today, Bausch Health market cap is 2.14B.
What Is the Bausch Health (BHC) Share Price Target?
The average 12-month share price target for Bausch Health is 7.57, with a high estimate of 9 and a low estimate of 6. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Neutral and +32.37% Upside potential.
What Is Bausch Health's Earnings Per Share (TTM)?
The Bausch Health EPS (TTM) is -3.25.
When Is the Next Bausch Health Earnings Date?
Bausch Health will release its next earnings report on 05-08-2026.
From a Technical Analysis Perspective, Is BHC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Bausch Health Trade On?
Bausch Health is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Bausch Health?
The stock symbol for Bausch Health is "BHC."
How Many Times Has Bausch Health Stock Split?
Bausch Health has split 3 times.
How Many Employees Does Bausch Health Have?
Bausch Health has 20300 employees.
What Is the BHC Premarket Price?
BHC's last pre-market stock price is 5.75. The pre-market share volume is 2,090.00, and the stock has changed by 0.03, or 0.52%.
What Is the BHC After Hours Price?
BHC's last after hours stock price is 5.90, the stock has changed by 0.18, or 3.15%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.